Related Experiment Video
Updated: Aug 9, 2026
04:34
Surgical Treatment of an Endolymphatic Sac Tumor
Published on: May 26, 2023
Ewing's sarcoma of the mandible
A W Langman1, M J Kaplan, K Matthay
1Department of Otolaryngology-Head and Neck Surgery, University of California, San Francisco 94143.
Summary
Ewing's sarcoma cure rates have risen to 75% through combined local therapy and chemotherapy. For mandibular tumors, surgery is preferred over radiation to minimize functional loss and disfigurement.
Area of Science:
- Oncology
- Surgical Oncology
- Pediatric Oncology
Background:
- Ewing's sarcoma treatment has evolved significantly, improving patient outcomes.
- Multimodal therapy combining local treatments and systemic chemotherapy is standard.
Observation:
- Cure rates for Ewing's sarcoma have dramatically increased from 10% to 75%.
- This improvement is attributed to the integration of local therapy and aggressive multi-drug chemotherapy.
- The combination therapy aims to reduce local recurrence and prevent distant metastases.
Findings:
- In mandibular Ewing's sarcoma, complete surgical resection is the preferred local control method.
- Surgery is favored when it can be achieved with minimal functional impairment and cosmetic deformity.
- Irradiation is a secondary option for local control in specific circumstances.
Implications:
- Optimized treatment strategies enhance survival rates for Ewing's sarcoma patients.
- Surgical intervention in mandibular Ewing's sarcoma offers better functional and aesthetic preservation.
- Further research may refine multimodal approaches for improved Ewing's sarcoma management.
